CCK2 receptors in chronic pain

被引:6
|
作者
LaVigne, Justin E. [1 ]
Alles, Sascha R. A. [1 ]
机构
[1] Univ New Mexico, Sch Med, Dept Anesthesiol & Crit Care Med, Albuquerque, NM 87109 USA
关键词
CCK2; Cholecystokinin; Chronic pain; Non-opioid treatment; PREVENTS MORPHINE-TOLERANCE; ANTAGONIST L-365,260; CHOLECYSTOKININ-OCTAPEPTIDE; B RECEPTOR; SPINAL CHOLECYSTOKININ; SELECTIVE ANTAGONIST; INDUCED HYPERALGESIA; INDUCED ANALGESIA; OPIOID ANALGESIA; NEUROPATHIC PAIN;
D O I
10.1016/j.ynpai.2022.100092
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The cholecystokinin receptor system, specifically cholecystokinin 2 receptor (CCK2R) is a historic target for pain management that has shown limited success. However, new approaches to target CCK2R have incited fresh enthusiasm for this target. In this mini-review, we discuss what is known about CCK2R in peripheral and central circuits under na & iuml;ve physiological conditions and under conditions of chronic pain, the interactions of CCK2Rs with opioids and briefly, recent efforts to develop new treatments targeting CCK2R for chronic pain.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Altered behavioural effects of ethanol and increased voluntary ethanol consumption in mice lacking CCK2 receptors
    Abramov, U
    Vasar, E
    Koks, S
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S19 - S19
  • [32] CCK2 R is involved in regulation of food intake
    Clerc, P
    Coll, M
    Perrin, C
    Burcelin, R
    Carpéné, C
    Valet, P
    Matsui, T
    Seva, C
    Fourmy, D
    Dufresne, M
    REGULATORY PEPTIDES, 2004, 122 (01) : 51 - 51
  • [33] Potential clinical indications for a CCK2 receptor antagonist
    Boyce, Malcolm
    Lloyd, Katie A.
    Pritchard, D. Mark
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 68 - 75
  • [34] Radiolabelling and Preliminary in vivo Study of a Small Molecule-based Ligand for CCK2 Receptors Targeting
    Asti, M.
    Verona, M.
    Rubagotti, S.
    Mastrotto, F.
    Marzaro, G.
    Di Marco, V.
    Corradetti, S.
    Realdon, N.
    Andrighetto, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S9 - S10
  • [35] Evidence that neither CCK1 nor CCK2/gastrin receptors in the duodenum/antrum are involved in the physiological regulation of the exocrine pancreas in pigs
    Pierzynowski, Stefan
    Rengman, Sofia
    Westrom, Bjorn
    GASTROENTEROLOGY, 2006, 130 (04) : A547 - A547
  • [36] Behavioral Profile of CCK2 Receptor-deficient Mice
    Valérie Daugé
    Angélique Sebret
    Françoise Beslot
    Toshimitsu Matsui
    Bernard P Roques
    Neuropsychopharmacology, 2001, 25 : 690 - 698
  • [37] Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin
    Smith, AJ
    McKernan, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (01) : 79 - 86
  • [38] Pharmacological analysis of CCK2 receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK2 receptor
    Nilsson, I
    Monstein, HJ
    Lindström, E
    Håkanson, R
    Svensson, S
    REGULATORY PEPTIDES, 2002, 103 (01) : 29 - 37
  • [39] CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon
    Fornai, Matteo
    Colucci, Rocchina
    Antonioli, Luca
    Baschiera, Fabio
    Ghisu, Narcisa
    Tucconi, Marco
    Goni, Giovanni
    Blandizzi, Corrado
    Del Tacca, Mario
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 557 (2-3) : 212 - 220
  • [40] Behavioral profile of CCK2 receptor-deficient mice
    Daugé, V
    Sebret, A
    Beslot, F
    Matsui, T
    Roques, BP
    NEUROPSYCHOPHARMACOLOGY, 2001, 25 (05) : 690 - 698